reglab/housing_qa huggingface dataset:
WA Rev Code § 69.41.080 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.080 - Animal control—Rules for possession and use of legend drugs.

RCW 69.41.080 Animal control—Rules for possession and use of legend drugs.Humane societies and animal control agencies registered with the pharmacy quality assurance commission under chapter 69.50 RCW and authorized to euthanize animals may purchase, possess, and administer approved legend drugs for the sole purpose of sedating animals prior to euthanasia, when necessary, and for use in chemical capture programs. For the purposes of this section, "approved legend drugs" means those legend drugs designated by the commission by rule as being approved for use by such societies and agencies for animal sedating or capture and does not include any substance regulated under chapter 69.50 RCW. Any society or agency so registered shall not permit persons to administer any legend drugs unless such person has demonstrated to the satisfaction of the commission adequate knowledge of the potential hazards involved in and the proper techniques to be used in administering the drugs.The commission shall promulgate rules to regulate the purchase, possession, and administration of legend drugs by such societies and agencies and to insure strict compliance with the provisions of this section. Such rules shall require that the storage, inventory control, administration, and recordkeeping for approved legend drugs conform to the standards adopted by the commission under chapter 69.50 RCW to regulate the use of controlled substances by such societies and agencies. The commission may suspend or revoke a registration under chapter 69.50 RCW upon a determination by the commission that the person administering legend drugs has not demonstrated adequate knowledge as herein provided. This authority is granted in addition to any other power to suspend or revoke a registration as provided by law.[ 2013 c 19 § 57; 1989 c 242 § 1.]
WA Rev Code § 69.41.085 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.085 - Medication assistance—Community-based care setting.

RCW 69.41.085 Medication assistance—Community-based care setting.Individuals residing in community-based care settings, such as adult family homes, assisted living facilities, and residential care settings for individuals with developmental disabilities, including an individual's home, may receive medication assistance. Nothing in this chapter affects the right of an individual to refuse medication or requirements relating to informed consent.[ 2012 c 10 § 45; 2003 c 140 § 12; 1998 c 70 § 1.]NOTES:Application—2012 c 10: See note following RCW 18.20.010.Effective date—2003 c 140: See note following RCW 18.79.040.
WA Rev Code § 69.41.100 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.100 - Legislative recognition and declaration.

RCW 69.41.100 Legislative recognition and declaration.The legislature recognizes the responsibility of the state to insure that the citizens of the state are offered a choice between generic drugs and brand name drugs and the benefit of quality pharmaceutical products at competitive prices. Advances in the drug industry resulting from research and the elimination of counterfeiting of prescription drugs should benefit the users of the drugs. Pharmacy must continue to operate with accountability and effectiveness. The legislature hereby declares it to be the policy of the state that its citizens receive safe and therapeutically effective drug products at the most reasonable cost consistent with high drug quality standards.[ 1986 c 52 § 1; 1977 ex.s. c 352 § 1.]NOTES:Severability—1977 ex.s. c 352: "If any provision of this act, or its application to any person or circumstance is held invalid, the remainder of the act, or the application of the provision to other persons or circumstances is not affected." [ 1977 ex.s. c 352 § 10.]
WA Rev Code § 69.41.110 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.110 - Definitions.

RCW 69.41.110 Definitions.As used in RCW 69.41.100 through 69.41.180, the following words shall have the following meanings:(1) "Biological product" means any of the following, when applied to the prevention, treatment, or cure of a disease or condition of human beings: (a) A virus; (b) a therapeutic serum; (c) a toxin; (d) an antitoxin; (e) a vaccine; (f) blood, blood component, or derivative; (g) an allergenic product; (h) a protein, other than a chemically synthesized polypeptide, or an analogous product; or (i) arsphenamine, a derivative of arsphenamine, or any trivalent organic arsenic compound;(2) "Brand name" means the proprietary or trade name selected by the manufacturer and placed upon a drug, its container, label, or wrapping at the time of packaging;(3) "Generic name" means the official title of a drug or drug ingredients published in the latest edition of a nationally recognized pharmacopoeia or formulary;(4) "Interchangeable" means a biological product:(a) Licensed by the federal food and drug administration and determined to meet the safety standards for interchangeability pursuant to 42 U.S.C. Sec. 262(k)(4); or(b) Approved based on an application filed under section 505(b) of the federal food, drug, and cosmetic act that is determined by the federal food and drug administration to be therapeutically equivalent to an approved 505(b) biological product and is included in the 505(b) list maintained by the pharmacy quality assurance commission pursuant to RCW 69.41.196;(5) "Practitioner" means a physician, osteopathic physician and surgeon, dentist, veterinarian, or any other person authorized to prescribe drugs under the laws of this state;(6) "Substitute" means to dispense, with the practitioner's authorization, a "therapeutically equivalent" drug product or "interchangeable biological" drug product; and(7) "Therapeutically equivalent" means a drug product of the identical base or salt as the specific drug product prescribed with essentially the same efficacy and toxicity when administered to an individual in the same dosage regimen.[ 2015 c 242 § 1; 1979 c 110 § 1; 1977 ex.s. c 352 § 2.]NOTES:Reviser's note: The definitions in this section have been alphabetized pursuant to RCW 1.08.015(2)(k).
WA Rev Code § 69.41.120 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.120 - Prescriptions to contain instruction as to whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted—Out-of-state prescriptions—Form—Contents—Procedure.

RCW 69.41.120 Prescriptions to contain instruction as to whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted—Out-of-state prescriptions—Form—Contents—Procedure.(1) Every drug prescription shall contain an instruction on whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted in its place, unless substitution is permitted under a prior-consent authorization.If a written prescription is involved, the prescription must be legible and the form shall have two signature lines at opposite ends on the bottom of the form. Under the line at the right side shall be clearly printed the words "DISPENSE AS WRITTEN." Under the line at the left side shall be clearly printed the words "SUBSTITUTION PERMITTED." The practitioner shall communicate the instructions to the pharmacist by signing the appropriate line. No prescription shall be valid without the signature of the practitioner on one of these lines. In the case of a prescription issued by a practitioner in another state that uses a one-line prescription form or variation thereof, the pharmacist may substitute a therapeutically equivalent generic drug or interchangeable biological product unless otherwise instructed by the practitioner through the use of the words "dispense as written," words of similar meaning, or some other indication.(2) If an oral prescription is involved, the practitioner or the practitioner's agent shall instruct the pharmacist as to whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted in its place. The pharmacist shall note the instructions on the file copy of the prescription.(3) The pharmacist shall note the manufacturer of the drug dispensed on the file copy of a written or oral prescription.(4) The pharmacist shall retain the file copy of a written or oral prescription for the same period of time specified in RCW 18.64.245 for retention of prescription records.[ 2015 c 242 § 2; 2000 c 8 § 3; 1990 c 218 § 1; 1979 c 110 § 2; 1977 ex.s. c 352 § 3.]NOTES:Findings—Intent—2000 c 8: See note following RCW 69.41.010.
WA Rev Code § 69.41.125 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.125 - Interchangeable biological product may be substituted for biological product—Exception—Wholesale price less.

RCW 69.41.125 Interchangeable biological product may be substituted for biological product—Exception—Wholesale price less.Unless the prescribed biological product is requested by the patient or the patient's representative, if "substitution permitted" is marked on the prescription as provided in RCW 69.41.120, the pharmacist must substitute an interchangeable biological product that he or she has in stock for the biological product prescribed if the wholesale price for the interchangeable biological product to the pharmacist is less than the wholesale price for the biological product prescribed.[ 2015 c 242 § 3.]
WA Rev Code § 69.41.130 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.130 - Savings in price to be passed on to purchaser.

RCW 69.41.130 Savings in price to be passed on to purchaser.Unless the brand name drug is requested by the patient or the patient's representative, the pharmacist shall substitute an equivalent drug product which he or she has in stock if its wholesale price to the pharmacist is less than the wholesale price of the prescribed drug product, and at least sixty percent of the savings shall be passed on to the purchaser.[ 2012 c 117 § 365; 1986 c 52 § 2; 1979 c 110 § 3; 1977 ex.s. c 352 § 4.]
WA Rev Code § 69.41.140 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.140 - Minimum manufacturing standards and practices.

RCW 69.41.140 Minimum manufacturing standards and practices.A pharmacist may not substitute a product under the provisions of this section unless the manufacturer has shown that the drug has been manufactured with the following minimum good manufacturing standards and practices:(1) Maintain quality control standards equal to those of the Food and Drug Administration;(2) Comply with regulations promulgated by the Food and Drug Administration.[ 1979 c 110 § 4; 1977 ex.s. c 352 § 5.]
WA Rev Code § 69.41.150 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.150 - Liability of practitioner, pharmacist.

RCW 69.41.150 Liability of practitioner, pharmacist.(1) A practitioner who authorizes a prescribed drug shall not be liable for any side effects or adverse reactions caused by the manner or method by which a substituted drug product is selected or dispensed.(2) A pharmacist who substitutes a therapeutically equivalent drug product pursuant to RCW 69.41.100 through 69.41.180 as now or hereafter amended assumes no greater liability for selecting the dispensed drug product than would be incurred in filling a prescription for a drug product prescribed by its established name.(3) A pharmacist who substitutes a preferred drug for a nonpreferred drug pursuant to RCW 69.41.190 assumes no greater liability for substituting the preferred drug than would be incurred in filling a prescription for the preferred drug when prescribed by name.(4) A pharmacist who selects an interchangeable biological product to be dispensed pursuant to RCW 69.41.100 through 69.41.180, and the pharmacy for which the pharmacist is providing service, assumes no greater liability for selecting the interchangeable biological product than would be incurred in filling a prescription for the interchangeable biological product when prescribed by name. The prescribing practitioner is not liable for a pharmacist's act or omission in selecting, preparing, or dispensing an interchangeable biological product under this section.[ 2015 c 242 § 6; 2003 1st sp.s. c 29 § 6; 1979 c 110 § 5; 1977 ex.s. c 352 § 6.]NOTES:Finding—Intent—Severability—Conflict with federal requirements—Effective date—2003 1st sp.s. c 29: See notes following RCW 74.09.650.
WA Rev Code § 69.41.160 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.160 - Pharmacy signs as to substitution for prescribed drugs.

RCW 69.41.160 Pharmacy signs as to substitution for prescribed drugs.Every pharmacy shall post a sign in a location at the prescription counter that is readily visible to patrons stating, "Under Washington law, a less expensive interchangeable biological product or equivalent drug may in some cases be substituted for the drug prescribed by your doctor. Such substitution, however, may only be made with the consent of your doctor. Please consult your pharmacist or physician for more information."[ 2015 c 242 § 7; 1979 c 110 § 6; 1977 ex.s. c 352 § 7.]
WA Rev Code § 69.41.170 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.170 - Coercion of pharmacist prohibited—Penalty.

RCW 69.41.170 Coercion of pharmacist prohibited—Penalty.It shall be unlawful for any employer to coerce, within the meaning of RCW 9A.36.070, any pharmacist to dispense a generic drug or to substitute a generic drug for another drug. A violation of this section shall be punishable as a misdemeanor.[ 1977 ex.s. c 352 § 8.]
WA Rev Code § 69.41.180 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.180 - Rules.

RCW 69.41.180 Rules.The pharmacy quality assurance commission may adopt any necessary rules under chapter 34.05 RCW for the implementation, continuation, or enforcement of RCW 69.41.100 through 69.41.180, including, but not limited to, a list of therapeutically or nontherapeutically equivalent drugs which, when adopted, shall be provided to all registered pharmacists in the state and shall be updated as necessary.[ 2013 c 19 § 58; 1979 c 110 § 7; 1977 ex.s. c 352 § 9.]
WA Rev Code § 69.41.193 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.193 - Dispensing of biological product—Entry of product into electronic records system—Communication—Exceptions.

RCW 69.41.193 Dispensing of biological product—Entry of product into electronic records system—Communication—Exceptions. (Expires August 1, 2025.)(1) Within five business days following the dispensing of a biological product, the dispensing pharmacist or the pharmacist's designee must make an entry of the specific product provided to the patient, including either the name of the product and the manufacturer or the federal food and drug administration's national drug code, provided that the name of the product and the name of the manufacturer are accessible to a practitioner in an electronic records system that can be electronically accessed by the patient's practitioner through:(a) An interoperable electronic medical records system;(b) An electronic prescribing technology;(c) A pharmacy benefit management system; or(d) A pharmacy record.(2) Entry into an electronic records system, as described in subsection (1) of this section, is presumed to provide notice to the practitioner. Otherwise, the pharmacist must communicate to the practitioner the specific product provided to the patient, including the name of the product and manufacturer, using facsimile, telephone, electronic transmission, or other prevailing means.(3) No entry or communication pursuant to this section is required if:(a) There is no interchangeable biological product for the product prescribed;(b) A refill prescription is not changed from the product dispensed on the prior filling of the prescription; or(c) The pharmacist or the pharmacist's designee and the practitioner communicated before dispensing and the communication included confirmation of the specific product to be provided to the patient, including the name of the product and the manufacturer.(4) This section expires August 1, 2025.[ 2020 c 21 § 1; 2015 c 242 § 4.]
WA Rev Code § 69.41.196 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.196 - List of interchangeable biological products—Pharmacy quality assurance commission to maintain link on website.

RCW 69.41.196 List of interchangeable biological products—Pharmacy quality assurance commission to maintain link on website.The pharmacy quality assurance commission shall maintain a link on its website to the current list of all biological products determined by the federal food and drug administration as interchangeable. The commission shall maintain a list of all biological products approved as therapeutically equivalent by the federal food and drug administration through the approval process specified in 505(b) of the federal food, drug, and cosmetic act. The commission shall make the 505(b) list accessible to pharmacies.[ 2015 c 242 § 5.]
WA Rev Code § 69.41.200 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.200 - Requirements for identification of legend drugs—Marking.

RCW 69.41.200 Requirements for identification of legend drugs—Marking.(1) No legend drug in solid dosage form may be manufactured or commercially distributed within this state unless it has clearly marked or imprinted on it an individual symbol, number, company name, words, letters, marking, or National Drug Code number identifying the drug and the manufacturer or distributor of such drug.(2) No manufacturer or distributor may sell any legend drug contained within a bottle, vial, carton, or other container, or in any way affixed or appended to or enclosed within a package of any kind designed or intended for delivery in such container or package to an ultimate consumer within this state unless such container or package has clearly and permanently marked or imprinted on it an individual symbol, number, company name, words, letters, marking, or National Drug Code number identifying the drug and the manufacturer or distributor of such drug.(3) Whenever the distributor of a legend drug does not also manufacture it, the names and places of businesses of both shall appear on the stock container or package label in words that truly distinguish each.[ 1980 c 83 § 1.]
WA Rev Code § 69.41.210 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.210 - Definitions.

RCW 69.41.210 Definitions.The terms defined in this section shall have the meanings indicated when used in RCW 69.41.200 through 69.41.260.(1) "Commission" means the pharmacy quality assurance commission.(2) "Distributor" means any corporation, person, or other entity which distributes for sale a legend drug under its own label even though it is not the actual manufacturer of the legend drug.(3) "Legend drug" means any drugs which are required by state law or regulation of the commission to be dispensed as prescription only or are restricted to use by prescribing practitioners only and shall include controlled substances in Schedules II through V of chapter 69.50 RCW.(4) "Solid dosage form" means capsules or tablets or similar legend drug products intended for administration and which could be ingested orally.[ 2013 c 19 § 59; 1980 c 83 § 2.]NOTES:Reviser's note: The definitions in this section have been alphabetized pursuant to RCW 1.08.015(2)(k).
WA Rev Code § 69.41.220 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.220 - Published lists of drug imprints—Requirements for.

RCW 69.41.220 Published lists of drug imprints—Requirements for.Each manufacturer and distributor shall publish and provide to the commission by filing with the department printed material which will identify each current imprint used by the manufacturer or distributor. The commission shall be notified of any change by the filing of any change with the department. This information shall be provided by the department to all pharmacies licensed in the state of Washington, poison control centers, and hospital emergency rooms.[ 2016 c 148 § 16; 1989 1st ex.s. c 9 § 428; 1980 c 83 § 3.]NOTES:Effective date—Severability—1989 1st ex.s. c 9: See RCW 43.70.910 and 43.70.920.
WA Rev Code § 69.41.230 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.230 - Drugs in violation are contraband.

RCW 69.41.230 Drugs in violation are contraband.Any legend drug prepared or manufactured or offered for sale in violation of this chapter or implementing rules shall be contraband and subject to seizure under the provisions of RCW 69.41.060.[ 1980 c 83 § 4.]
WA Rev Code § 69.41.240 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.240 - Rules—Labeling and marking.

RCW 69.41.240 Rules—Labeling and marking.The commission shall have authority to promulgate rules and regulations for the enforcement and implementation of RCW 69.41.050 and 69.41.200 through 69.41.260.[ 2013 c 19 § 60; 1980 c 83 § 5.]
WA Rev Code § 69.41.250 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.250 - Exemptions.

RCW 69.41.250 Exemptions.(1) The commission, upon application of a manufacturer, may exempt a particular legend drug from the requirements of RCW 69.41.050 and 69.41.200 through 69.41.260 on the grounds that imprinting is infeasible because of size, texture, or other unique characteristics.(2) The provisions of RCW 69.41.050 and 69.41.200 through 69.41.260 shall not apply to any legend drug which is prepared or manufactured by a pharmacy in this state and is for the purpose of retail sale from such pharmacy and not intended for resale.[ 2013 c 19 § 61; 1980 c 83 § 6.]
WA Rev Code § 69.41.260 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.41 - Legend Drugs—Prescription Drugs.|69.41.260 - Manufacture or distribution for resale—Requirements.

RCW 69.41.260 Manufacture or distribution for resale—Requirements.All legend drugs manufactured or distributed for resale to any entity in this state other than the ultimate consumer shall meet the requirements of RCW 69.41.050 and 69.41.200 through 69.41.260 from a date eighteen months after June 12, 1980.[ 1980 c 83 § 7.]